356 related articles for article (PubMed ID: 26485710)
1. Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis.
Jonkman LE; Rosenthal DM; Sormani MP; Miles L; Herbert J; Grossman RI; Inglese M
PLoS One; 2015; 10(10):e0129380. PubMed ID: 26485710
[TBL] [Abstract][Full Text] [Related]
2. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.
De Stefano N; Matthews PM; Filippi M; Agosta F; De Luca M; Bartolozzi ML; Guidi L; Ghezzi A; Montanari E; Cifelli A; Federico A; Smith SM
Neurology; 2003 Apr; 60(7):1157-62. PubMed ID: 12682324
[TBL] [Abstract][Full Text] [Related]
3. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Calabrese M; Agosta F; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Rinaldi L; Perini P; Gallo P; Filippi M
Arch Neurol; 2009 Sep; 66(9):1144-50. PubMed ID: 19752305
[TBL] [Abstract][Full Text] [Related]
4. Identical lesion morphology in primary progressive and relapsing-remitting MS--an ultrahigh field MRI study.
Kuchling J; Ramien C; Bozin I; Dörr J; Harms L; Rosche B; Niendorf T; Paul F; Sinnecker T; Wuerfel J
Mult Scler; 2014 Dec; 20(14):1866-71. PubMed ID: 24781284
[TBL] [Abstract][Full Text] [Related]
5. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
[TBL] [Abstract][Full Text] [Related]
6. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study.
Ramasamy DP; Benedict RH; Cox JL; Fritz D; Abdelrahman N; Hussein S; Minagar A; Dwyer MG; Zivadinov R
J Neurol Sci; 2009 Jul; 282(1-2):47-54. PubMed ID: 19201003
[TBL] [Abstract][Full Text] [Related]
7. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
[TBL] [Abstract][Full Text] [Related]
8. Subcortical gray matter atrophy is associated with cognitive deficit in multiple sclerosis but not in systemic lupus erythematosus patients.
Kalinowska-Łyszczarz A; Pawlak MA; Pietrzak A; Pawlak-Buś K; Leszczyński P; Puszczewicz M; Majewski D; Paprzycki W; Kozubski W; Michalak S
Lupus; 2018 Apr; 27(4):610-620. PubMed ID: 28992796
[TBL] [Abstract][Full Text] [Related]
9. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
Hojjat SP; Kincal M; Vitorino R; Cantrell CG; Feinstein A; Zhang L; Lee L; O'Connor P; Carroll TJ; Aviv RI
AJNR Am J Neuroradiol; 2016 Aug; 37(8):1454-61. PubMed ID: 27012299
[TBL] [Abstract][Full Text] [Related]
10. The impact of deep grey matter volume on cognition in multiple sclerosis.
Lorefice L; Carta E; Frau J; Contu F; Casaglia E; Coghe G; Barracciu MA; Cocco E; Fenu G
Mult Scler Relat Disord; 2020 Oct; 45():102351. PubMed ID: 32731200
[TBL] [Abstract][Full Text] [Related]
11. Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment.
Amato MP; Bartolozzi ML; Zipoli V; Portaccio E; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
Neurology; 2004 Jul; 63(1):89-93. PubMed ID: 15249616
[TBL] [Abstract][Full Text] [Related]
12. Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study.
Damjanovic D; Valsasina P; Rocca MA; Stromillo ML; Gallo A; Enzinger C; Hulst HE; Rovira A; Muhlert N; De Stefano N; Bisecco A; Fazekas F; Arévalo MJ; Yousry TA; Filippi M
AJNR Am J Neuroradiol; 2017 Jan; 38(1):18-24. PubMed ID: 27686487
[TBL] [Abstract][Full Text] [Related]
13. Pattern of gray matter volumes related to retinal thickness and its association with cognitive function in relapsing-remitting MS.
Stellmann JP; Cetin H; Young KL; Hodecker S; Pöttgen J; Bittersohl D; Hassenstein A; Oberwahrenbrock T; Heesen C; Siemonsen S
Brain Behav; 2017 Feb; 7(2):e00614. PubMed ID: 28239524
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study.
Yaldizli Ö; Pardini M; Sethi V; Muhlert N; Liu Z; Tozer DJ; Samson RS; Wheeler-Kingshott CA; Yousry TA; Miller DH; Chard DT
Mult Scler; 2016 Feb; 22(2):150-9. PubMed ID: 26014608
[TBL] [Abstract][Full Text] [Related]
15. MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction.
Anderson VM; Fisniku LK; Altmann DR; Thompson AJ; Miller DH
Mult Scler; 2009 Jul; 15(7):811-7. PubMed ID: 19465449
[TBL] [Abstract][Full Text] [Related]
16. Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis.
Pravatà E; Rocca MA; Valsasina P; Riccitelli GC; Gobbi C; Comi G; Falini A; Filippi M
Mult Scler; 2017 Dec; 23(14):1864-1874. PubMed ID: 28169581
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of cortical lesions in patients with multiple sclerosis: A neuropsychological and neuroimaging study.
Matsushita F; Kida H; Tabei KI; Nakano C; Matsuura K; Ii Y; Sasaki R; Taniguchi A; Narita Y; Maeda M; Satoh M; Tomimoto H
Brain Behav; 2018 Mar; 8(3):e00934. PubMed ID: 29541544
[TBL] [Abstract][Full Text] [Related]
18. Brain atrophy patterns in multiple sclerosis patients treated with natalizumab and its clinical correlates.
Rekik A; Aissi M; Rekik I; Mhiri M; Frih MA
Brain Behav; 2022 May; 12(5):e2573. PubMed ID: 35398999
[TBL] [Abstract][Full Text] [Related]
19. Tissue damage detected by quantitative gradient echo MRI correlates with clinical progression in non-relapsing progressive MS.
Xiang B; Brier MR; Kanthamneni M; Wen J; Snyder AZ; Yablonskiy DA; Cross AH
Mult Scler; 2022 Sep; 28(10):1515-1525. PubMed ID: 35196933
[TBL] [Abstract][Full Text] [Related]
20. Opposite roles of NMDA receptors in relapsing and primary progressive multiple sclerosis.
Rossi S; Studer V; Moscatelli A; Motta C; Coghe G; Fenu G; Caillier S; Buttari F; Mori F; Barbieri F; Castelli M; De Chiara V; Monteleone F; Mancino R; Bernardi G; Baranzini SE; Marrosu MG; Oksenberg JR; Centonze D
PLoS One; 2013; 8(6):e67357. PubMed ID: 23840674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
